Borody T.J.

de Vos W.M.

Dietrich M.

Eiseman B.

Heidt P.J.

Khoruts A.

Raibaud P.

van der Waaij D.

Vrieze A.

Microbial Biotechnology

PubMed

Willem M. Vos

Crossref

Fame and future of faecal transplantations – developing next‐generation therapies with synthetic microbiomes

While practised for over thousand years, there is presently a renaissance in the interest of using of faecal transplantations to modify the intestinal microbiota of patients. This clinical practice consists of delivering large amounts of bowel microbes in various forms into the intestinal tract of the recipient that usually has been cleared previously. The major reason for the popularity of faecal transplantations is their effectiveness in treating a variety of diseases. Hence, there is a need to develop this procedure to the next level. While there are various developments to select, standardize and store the donor microbiota, it is more challenging to understand the intestinal microbial communities and develop ways to deliver these via robust biotechnological processes. The various approaches that have been followed to do so are discussed in this contribution that is also addressing the concept of the minimal microbiome as well as the production of the synthetic communities that can be instrumental in new therapeutic avenues to modify the intestinal microbiota

de Vos, W.M.

NARCIS 

Fame and future of faecal transplantations - developing next-generation therapies with synthetic microbiomes

Vos, W.M., de

Wageningen Yield 

de Vos, Willem M.

Helsingin yliopiston digitaalinen arkisto

Name not available

A microbial world within us.

and the Human Microbiome Project Consortium

and the MetaHit Consortium

and the MetaHit Consortium (2010) A human gut microbial gene catalogue established by metagenomic sequencing.

Bacteriootherapy for Clostridium difficile diarrhea.

Bacteriotherapy for chronic constipation – long term follow up.

Bacteriotherapy for chronic relapsing Clostridium difficile diarrhoea in six patients.

Bacteriotherapy for Clostridium difficile diarrhoea.

Bacteriotherapy in Chronic Fatigue Syndrome (CFS): a retrospective review.

Bacteriotherapy using fecal ﬂora: toying with human motions.

Changes in the composition of the human fecal microbiome after bacteriotherapy for recurrent Clostridium difficile-associated diarrhea.

D-lactic acidosis in a boy with short bowel syndrome.

Deﬁned cultures and prospects.

Diversity of the human gastrointestinal tract microbiota revisited.

Duodenal infusion of donor feces for recurrent Clostridium difficile.

Effect of broad- and narrowspectrum antimicrobials on Clostridium difficile and microbial diversity in a model of the distal colon.

Etablissment d’une ﬂore microbienne dans le tube digest d’enfants axeniques eleves en isolateur.

Evaluation of aviguard, a commercial competitive exclusion product for efficacy and after-effect on the antibody response of chicks to Salmonella.

Extensive personal human gut microbiota culture collections characterized and manipulated in gnotobiotic mice.

Fecal enema as an adjunct in the enterocolitis.

Fecal microbiota transplantation – an old therapy comes of age.

Fecal Microbiota Transplantation (FMT) in multiple sclerosis (MS).

Fecal microbiota transplantation and emerging applications.

Fecal microbiota transplantation: techniques, applications, and issues.

Fecal transplant against relapsing Clostridium difficile-associated diarrhea in 32 patients.

Fecal transplant: a safe and sustainable clinical therapy for restoring intestinal microbial balance in human disease?

Fecal transplantation, through colonoscopy, is effective therapy for recurrent Clostridium difficile infection.

Genetic diversity of viable, injured, and dead fecal bacteria assessed by ﬂuorescence-activated cell sorting and 16S rRNA gene analysis.

Gnotobiotic care of patients with immunologic deﬁciency diseases.

Going viral: next-generation sequencing applied to phage populations in the human gut.

Gut bacteria–host metabolic interplay during conventionalisation of the mouse germfree colon.

High throughput diversity and functionality analysis of the gastrointestinal tract microbiota.

High-throughput DNA sequence analysis reveals stable engraftment of gut microbiota following transplantation of previously frozen fecal bacteria.

in the rumen of cattle fed high grain diets.

Intestinal microbiota in healthy adults: temporal analysis reveals individual and common core and relation to digestive symptoms.

Long-term monitoring of the human intestinal microbiota composition.

Microbes maketh man.

Multiparametric ﬂow cytometry and cell sorting for the assessment of viable, injured, and dead biﬁdobacterium cells during bile salt stress.

New aspects of Salmonella infection in broiler production.

On the carrier state of bacteriophages in starter lactococci: an elementary explanation involving a bacteriophage-resistance plasmid.

Prevention of Salmonella Typhimurium colonization and organ invasion by combination treatment in broiler chicks.

Reconventionalization following antibiotic decontamination in man and animals.

Role of the intestinal microbiome in health and disease: from correlation to causation.

Should we standardize the 1,700-year-old fecal microbiota transplantation?

Standardized frozen preparation for transplantation of fecal microbiota for recurrent Clostridium difficile infection.

Stool substitute transplant therapy for the eradication of Clostridium difficile infection: ‘RePOOPulating’ the gut.

Systematic review of intestinal microbiota transplantation (fecal bacteriotherapy) for recurrent Clostridium difficile infection.

Systems biology of the gut: the interplay of food, microbiota and host at the mucosal interface.

Systems solutions by lactic acid bacteria: from paradigms to practice. Micr Cell Fact 10: S2– S20.

Targeted restoration of the intestinal microbiota with a simple, deﬁned bacteriotherapy resolves relapsing Clostridium difficile disease in mice.

Temperature gradient gel electrophoresis analysis of 16S rRNA from human fecal samples reveals stable and host-speciﬁc communities of active bacteria.

The Author. Microbial Biotechnology published by

The development of calves raised without protozoa and certain other characteristic rumen microorganisms.

The human gut virome: inter-individual variation and dynamic response to diet.

The interaction between bacteria and bile.

The micro-Petri dish, a million-well growth chip for the culture and high-throughput screening of microorganisms.

The microbial contribution to human fecal mass.

The use of a human donor ﬂora for recontamination following antibiotic decontamination.

Toward an understanding of changes in diversity associated with fecal microbiome transplantation based on 16S rRNA gene deep sequencing.

Transfer of intestinal microbiota from lean donors increases insulin sensitivity in individuals with metabolic syndrome.

Treatment of ulcerative colitis by implantation of normal colonic ﬂora.

Treatment of ulcerative colitis using fecal bacteriotherapy.

Where bio meets nano: the many uses for nanoporous aluminum oxide in biotechnology.

https://helda.helsinki.fi/bitstream/10138/232606/1/Vos_2013_Microbial_Biotechnology.pdf

Fame and future of faecal transplantations - developing next-generation therapies with synthetic microbiomes

Abstract

Similar works

Full text

Available Versions

Crossref

NARCIS

Wageningen Yield

Helsingin yliopiston digitaalinen arkisto

Name not available